Expertise in
13
conditions

Sven M. Poli

Hoppe Seyler Str. 3, 
Tuebingen, BW, DE 
Expertise in
13
conditions
Hoppe Seyler Str. 3, 
Tuebingen, BW, DE 

Overview

Sven Poli practices practicing medicine in Tuebingen, Germany.

Mr. Poli is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Retinal Artery Occlusion, Stroke, Mesenteric Venous Thrombosis, Thrombectomy, and Stent Placement.

He is actively involved in clinical research, co-authoring 212 peer reviewed articles and participating in 5 clinical trials.

Gender

Male

Locations

Hoppe Seyler Str. 3, Tuebingen, BW 72076, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

EdoxabaN foR IntraCranial Hemorrhage Survivors With Atrial Fibrillation (ENRICH-AF)
EdoxabaN foR IntraCranial Hemorrhage Survivors With Atrial Fibrillation (ENRICH-AF)
Enrollment Status: Completed
Publish Date: September 01, 2026
Intervention Type: Drug, Other
Study Drug: Edoxaban
Study Phase: Phase 4
Early Versus Late Initiation of Direct Oral Anticoagulants in Post-ischaemic Stroke Patients With Atrial fibrillatioN (ELAN): an International, Multicentre, Randomised-controlled, Two-arm, Assessor-blinded Trial
Early Versus Late Initiation of Direct Oral Anticoagulants in Post-ischaemic Stroke Patients With Atrial fibrillatioN (ELAN): an International, Multicentre, Randomised-controlled, Two-arm, Assessor-blinded Trial
Enrollment Status: Completed
Publish Date: July 18, 2023
Intervention Type: Drug
Study Phase: Not Applicable
Apixaban for Treatment of Embolic Stroke of Undetermined Source (ATTICUS Randomized Trial)
Apixaban for Treatment of Embolic Stroke of Undetermined Source (ATTICUS Randomized Trial)
Enrollment Status: Completed
Publish Date: October 13, 2021
Intervention Type: Drug
Study Drugs: Apixaban, Aspirin
Study Phase: Phase 3
Revacept, an Inhibitor of Platelet Adhesion in Symptomatic Carotid Stenosis: A Phase II, Multicentre; Randomised, Dose-finding, Double-blind and Placebo Controlled Superiority Study With Parallel Groups
Revacept, an Inhibitor of Platelet Adhesion in Symptomatic Carotid Stenosis: A Phase II, Multicentre; Randomised, Dose-finding, Double-blind and Placebo Controlled Superiority Study With Parallel Groups
Enrollment Status: Completed
Publish Date: January 28, 2021
Intervention Type: Drug
Study Phase: Phase 2
Minimally Invasive Surgery Plus Rt-PA for ICH Evacuation Phase III
Minimally Invasive Surgery Plus Rt-PA for ICH Evacuation Phase III
Enrollment Status: Completed
Publish Date: September 27, 2019
Intervention Type: Drug
Study Phase: Phase 3
View 4 Less Clinical Trials

212 Total Publications

Role of Perfusion Parameters on Outcomes and Safety of Endovascular Therapy in Posterior Cerebral Artery Stroke.
Role of Perfusion Parameters on Outcomes and Safety of Endovascular Therapy in Posterior Cerebral Artery Stroke.
Journal: Stroke
Published: July 09, 2026

Frequently Asked Questions about Sven M. Poli

Is Sven M. Poli a top-rated expert for Retinal Artery Occlusion?

MediFind is an objective health platform that identifies experts based on real-world data. Sven M. Poli is classified as an Elite expert for Retinal Artery Occlusion, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Sven M. Poli participate in research or clinical trials?

Yes. Sven M. Poli has published 212 articles and abstracts on conditions like Retinal Artery Occlusion. You can view a list of Sven M. Poli's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Poli's expertise for a condition
ConditionClose
View All 7 Advanced Conditions
View All 28 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile